S. Rubin

发表

Review of studies on metabolic genes and cancer in populations of African descent

Scott M Langevin, E. Taioli, C. Ragin, 2010, Genetics in Medicine.

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

S. Rubin, J. Lewis, M. Markman, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

S. Rubin, J. Lewis, M. Markman, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma.

J. Lewis, M. Markman, L. Almadrones, 1991, Gynecologic oncology.

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

R. Barakat, S. Rubin, J. Lewis, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

S. Rubin, J. Lewis, M. Markman, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.

R. Barakat, S. Rubin, J. Lewis, 1993, Gynecologic oncology.

Intestinal surgery in gynecologic oncology

Jl Lewis, V. Pierce, S. Rubin, 1989, Gynecologic oncology.

Palliative surgery for intestinal obstruction in advanced ovarian cancer

I. Benjamin, W. Hoskins, S. Rubin, 1989, Gynecologic oncology.

Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.

S. Rubin, J. Lewis, M. Markman, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.

R. Barakat, S. Rubin, J. Lewis, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.

N. Kemeny, J. Lewis, D. Kelsen, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG162).

R. Burger, D. Spriggs, M. Brady, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.

J. Crown, D. Fennelly, J. Curtin, 1992, Journal of the National Cancer Institute.

Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.

R. Barakat, P. Francis, J. Lewis, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.

S. Rubin, J. Lewis, M. Markman, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.

R. Barakat, J. Lewis, M. Markman, 1992, Gynecologic oncology.

Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer.

J. Lewis, M. Markman, L. Almadrones, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes.

R. Brookland, S. Rubin, B. Danoff, 1984, International journal of radiation oncology, biology, physics.

Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).

J. Lewis, M. Markman, W. Jones, 1989, Acta medica Austriaca.

A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma.

J. Lewis, M. Markman, W. Hoskins, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.

P. Saigo, S. Rubin, M. Markman, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paget's disease of the vulva.

J. Curtin, W. Jones, S. Rubin, 1991, Gynecologic oncology.

Celiac axis and superior mesenteric artery injury associated with left radical nephrectomy for locally advanced renal cell carcinoma.

J. Moul, D. Mcleod, J. Foley, 1991, The Journal of urology.

Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy.

J. Lewis, M. Markman, L. Almadrones, 1991, Gynecologic oncology.

Expression of P‐glycoprotein in epithelial ovarian cancer: Evaluation as a marker of multidrug resistance

Jl Lewis, M. Markman, P. Saigo, 1991, American journal of obstetrics and gynecology.

Sex or survival: trade-offs between quality and quantity of life.

C. Stocking, P. Singer, M. Siegler, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.

R. Barakat, J. Lewis, M. Markman, 1993, Gynecologic oncology.

Intraperitoneal therapy in the management of ovarian carcinoma.

J. Lewis, M. Markman, W. Jones, 1989, The Yale journal of biology and medicine.

Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?

R. Barakat, J. Lewis, M. Markman, 1992, Seminars in oncology.

Impact of age on survival of patients with ovarian cancer.

R. Barakat, J. Lewis, M. Markman, 1993, Gynecologic oncology.

Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer

Jl Lewis, M. Markman, S. Rubin, 1989, American journal of obstetrics and gynecology.

Quantification of doses to mediastinal lymph nodes in Hodgkin's disease.

D. Spelbring, S. Rubin, S. Vijayakumar, 1992, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Which patients can have their para-aortic node metastases controlled by para-aortic radiation.

S. Rubin, 1984, International journal of radiation oncology, biology, physics.

Intraperitoneal administration of Taxol in the management of ovarian cancer.

R. Barakat, J. Lewis, E. Rowinsky, 1993, Journal of the National Cancer Institute. Monographs.